Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

June 30, 2015

Conditions

Benign Prostatic Hyperplasia (BPH) Requiring Surgical Resection

Interventions

DRUG

Ertapenem

One single injection of 1g of ertapenem before surgery

Trial Locations (1)

HEGP Hospital, Paris

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02041767 - Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration | Biotech Hunter | Biotech Hunter